- call +1-201-465-4211
- email sales@mrinsights.biz
The selective delivery of chemotherapeutic agents to their site of action should increase therapeutic effectiveness and limit side effects. Most drug therapies currently available, however, exhibit little, if any specificity. Many times, a drug has limited or no access to its intended site of action or is prematurely metabolized or excreted. In other instances, the drug travels rather freely throughout the body and not only acts on the desired target tissues but also causes undesirable effects on nontarget tissues. This lack of target specificity is attributable, for the most part, to the formidable barriers that the body presents to the successful delivery of a drug from its site of administration to its site of action: a drug normally encounters or must by pass various molecules, enzymes, cells, membranes, and organs before reaching its designated target.
Scope of the Report:
This report studies the Site-Specific Drug Delivery market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Site-Specific Drug Delivery market by product type and applications/end industries.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Site-Specific Drug Delivery in US$ by following Product Segments.: Liposomal Doxorubicin, Liposomal Amphoteracin B, Liposomal Paclitaxel and other.
Company profiles are primarily based on public domain information including company
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
The global Site-Specific Drug Delivery market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Site-Specific Drug Delivery.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Other
Market Segment by Applications, can be divided into
Fungal Infection Therapy
Cancer & Tumor Therapy
Other
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Site-Specific Drug Delivery Market Overview
1.1 Product Overview and Scope of Site-Specific Drug Delivery
1.2 Classification of Site-Specific Drug Delivery by Types
1.2.1 Global Site-Specific Drug Delivery Revenue Comparison by Types (2017-2023)
1.2.2 Global Site-Specific Drug Delivery Revenue Market Share by Types in 2017
1.2.3 Liposomal Doxorubicin
1.2.4 Liposomal Amphoteracin B
1.2.5 Liposomal Paclitaxel
1.2.6 Other
1.3 Global Site-Specific Drug Delivery Market by Application
1.3.1 Global Site-Specific Drug Delivery Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Other
1.4 Global Site-Specific Drug Delivery Market by Regions
1.4.1 Global Site-Specific Drug Delivery Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Site-Specific Drug Delivery Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Site-Specific Drug Delivery Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Site-Specific Drug Delivery Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Site-Specific Drug Delivery Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Site-Specific Drug Delivery Status and Prospect (2013-2023)
1.5 Global Market Size of Site-Specific Drug Delivery (2013-2023)
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Business Overview
2.1.2 Site-Specific Drug Delivery Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Johnson & Johnson Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.2 Gilead Sciences
2.2.1 Business Overview
2.2.2 Site-Specific Drug Delivery Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Gilead Sciences Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pacira
2.3.1 Business Overview
2.3.2 Site-Specific Drug Delivery Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pacira Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sun Pharmaceutical
2.4.1 Business Overview
2.4.2 Site-Specific Drug Delivery Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sun Pharmaceutical Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.5 Luye Pharma
2.5.1 Business Overview
2.5.2 Site-Specific Drug Delivery Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Luye Pharma Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sigma-Tau Group
2.6.1 Business Overview
2.6.2 Site-Specific Drug Delivery Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sigma-Tau Group Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.7 Fudan-Zhangjiang
2.7.1 Business Overview
2.7.2 Site-Specific Drug Delivery Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Fudan-Zhangjiang Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.8 Teva Pharmaceutical
2.8.1 Business Overview
2.8.2 Site-Specific Drug Delivery Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Teva Pharmaceutical Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.9 CSPC
2.9.1 Business Overview
2.9.2 Site-Specific Drug Delivery Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 CSPC Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.10 Novartis
2.10.1 Business Overview
2.10.2 Site-Specific Drug Delivery Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Novartis Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.11 Kingond Pharm
2.11.1 Business Overview
2.11.2 Site-Specific Drug Delivery Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Kingond Pharm Site-Specific Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
3 Global Site-Specific Drug Delivery Market Competition, by Players
3.1 Global Site-Specific Drug Delivery Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Site-Specific Drug Delivery Players Market Share
3.2.2 Top 10 Site-Specific Drug Delivery Players Market Share
3.3 Market Competition Trend
4 Global Site-Specific Drug Delivery Market Size by Regions
4.1 Global Site-Specific Drug Delivery Revenue and Market Share by Regions
4.2 North America Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
4.3 Europe Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
4.5 South America Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
5 North America Site-Specific Drug Delivery Revenue by Countries
5.1 North America Site-Specific Drug Delivery Revenue by Countries (2013-2018)
5.2 USA Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
5.3 Canada Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
5.4 Mexico Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
6 Europe Site-Specific Drug Delivery Revenue by Countries
6.1 Europe Site-Specific Drug Delivery Revenue by Countries (2013-2018)
6.2 Germany Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
6.3 UK Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
6.4 France Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
6.5 Russia Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
6.6 Italy Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Site-Specific Drug Delivery Revenue by Countries
7.1 Asia-Pacific Site-Specific Drug Delivery Revenue by Countries (2013-2018)
7.2 China Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
7.3 Japan Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
7.4 Korea Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
7.5 India Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
8 South America Site-Specific Drug Delivery Revenue by Countries
8.1 South America Site-Specific Drug Delivery Revenue by Countries (2013-2018)
8.2 Brazil Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
8.3 Argentina Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
8.4 Colombia Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Site-Specific Drug Delivery by Countries
9.1 Middle East and Africa Site-Specific Drug Delivery Revenue by Countries (2013-2018)
9.2 Saudi Arabia Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
9.3 UAE Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
9.4 Egypt Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
9.5 Nigeria Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
9.6 South Africa Site-Specific Drug Delivery Revenue and Growth Rate (2013-2018)
10 Global Site-Specific Drug Delivery Market Segment by Type
10.1 Global Site-Specific Drug Delivery Revenue and Market Share by Type (2013-2018)
10.2 Global Site-Specific Drug Delivery Market Forecast by Type (2018-2023)
10.3 Liposomal Doxorubicin Revenue Growth Rate (2013-2023)
10.4 Liposomal Amphoteracin B Revenue Growth Rate (2013-2023)
10.5 Liposomal Paclitaxel Revenue Growth Rate (2013-2023)
10.6 Other Revenue Growth Rate (2013-2023)
11 Global Site-Specific Drug Delivery Market Segment by Application
11.1 Global Site-Specific Drug Delivery Revenue Market Share by Application (2013-2018)
11.2 Site-Specific Drug Delivery Market Forecast by Application (2018-2023)
11.3 Fungal Infection Therapy Revenue Growth (2013-2018)
11.4 Cancer & Tumor Therapy Revenue Growth (2013-2018)
11.5 Other Revenue Growth (2013-2018)
12 Global Site-Specific Drug Delivery Market Size Forecast (2018-2023)
12.1 Global Site-Specific Drug Delivery Market Size Forecast (2018-2023)
12.2 Global Site-Specific Drug Delivery Market Forecast by Regions (2018-2023)
12.3 North America Site-Specific Drug Delivery Revenue Market Forecast (2018-2023)
12.4 Europe Site-Specific Drug Delivery Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Site-Specific Drug Delivery Revenue Market Forecast (2018-2023)
12.6 South America Site-Specific Drug Delivery Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Site-Specific Drug Delivery Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Site-Specific Drug Delivery Picture
Table Product Specifications of Site-Specific Drug Delivery
Table Global Site-Specific Drug Delivery and Revenue (Million USD) Ma
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
